Speedbump article.

Can someone please tell me this guy is full of sh*t

"The dose escalation is showing the right sort of profile, it also isn’t indicating the “one shot” profile that TT-034 needs in order to be successful. In short, the data is scientifically extremely interesting (and I hope that BLT will publish it in an appropriate clinical journal in due course) but it’s not, so far, delivering on the company’s hype."

Is he right in saying that we will not ever make it to commercialization with TT-034 because it will "have no impact on human health?"

do not advertise external blogs/2015/10/25/another-benitec-speedbump/